The Supreme Court ruled unanimously on Thursday, June 13th, that Myriad Genomics Inc. may not retain exclusive rights to the use of DNA sequence information for breast cancer associated genes BRCA1 and BRCA2, stating that Myriad had not created anything new in identifying the genes.
Read MoreIt goes without saying that the world as we know it is becoming increasingly infused with technology. Besides the everyday devices—computers, cell phones, cameras, cars—huge advances are being made on a daily basis at the intersection of biology and technology. Areas like biorobotics, nanotechnology, geoengineering, genetically engineered organisms and global monitoring, for example, are gaining steam. In biorobotics, which also…
Read More The Supreme Court ruled unanimously on Thursday, June 13th, that Myriad Genomics Inc. may not retain exclusive rights to the use of DNA sequence information for breast cancer associated genes BRCA1 and BRCA2, stating that Myriad had not created anything new in identifying the genes.
It goes without saying that the world as we know it is becoming increasingly infused with technology. Besides the everyday devices—computers, cell phones, cameras, cars—huge advances are being made on a daily basis at the intersection of biology and technology. Areas like biorobotics, nanotechnology, geoengineering, genetically engineered organisms and global monitoring, for example, are gaining steam. In biorobotics, which also…